Daniel (Pete) Duncan, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Deglutition Disorders | 11 | 2024 | 626 | 4.960 |
Why?
|
Gastroesophageal Reflux | 9 | 2024 | 816 | 3.670 |
Why?
|
Respiratory Aspiration | 4 | 2023 | 89 | 1.800 |
Why?
|
Deglutition | 3 | 2023 | 208 | 0.900 |
Why?
|
Bronchiectasis | 1 | 2022 | 139 | 0.750 |
Why?
|
Laryngomalacia | 1 | 2021 | 32 | 0.750 |
Why?
|
Anti-Ulcer Agents | 1 | 2021 | 112 | 0.720 |
Why?
|
Esophagitis, Peptic | 1 | 2021 | 76 | 0.710 |
Why?
|
Blood Vessel Prosthesis | 7 | 2015 | 953 | 0.690 |
Why?
|
Food Additives | 1 | 2019 | 23 | 0.670 |
Why?
|
Hospitalization | 6 | 2022 | 10634 | 0.630 |
Why?
|
Proton Pump Inhibitors | 2 | 2024 | 529 | 0.600 |
Why?
|
Pneumonia, Aspiration | 1 | 2018 | 145 | 0.590 |
Why?
|
Fluoroscopy | 4 | 2024 | 944 | 0.570 |
Why?
|
Nutritional Support | 1 | 2019 | 172 | 0.570 |
Why?
|
Child, Hospitalized | 1 | 2018 | 182 | 0.560 |
Why?
|
Laryngeal Diseases | 1 | 2019 | 243 | 0.510 |
Why?
|
Dioxoles | 1 | 2015 | 95 | 0.480 |
Why?
|
Infant | 13 | 2024 | 36045 | 0.460 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2015 | 301 | 0.440 |
Why?
|
Tissue Engineering | 6 | 2015 | 1868 | 0.440 |
Why?
|
Pneumonia | 1 | 2023 | 2127 | 0.400 |
Why?
|
Constriction, Pathologic | 2 | 2015 | 1097 | 0.390 |
Why?
|
Benzamides | 1 | 2015 | 1363 | 0.320 |
Why?
|
Muscular Dystrophies, Limb-Girdle | 1 | 2006 | 62 | 0.260 |
Why?
|
Boston | 4 | 2019 | 9298 | 0.250 |
Why?
|
Pediatrics | 1 | 2019 | 3586 | 0.230 |
Why?
|
Retrospective Studies | 12 | 2023 | 79984 | 0.210 |
Why?
|
Emergency Service, Hospital | 1 | 2022 | 7798 | 0.200 |
Why?
|
Practice Guidelines as Topic | 1 | 2019 | 7366 | 0.200 |
Why?
|
Family Health | 1 | 2006 | 1256 | 0.190 |
Why?
|
Dendritic Cell Sarcoma, Follicular | 1 | 2021 | 30 | 0.190 |
Why?
|
Muscle Proteins | 1 | 2006 | 1150 | 0.180 |
Why?
|
Prospective Studies | 5 | 2024 | 54092 | 0.180 |
Why?
|
Vena Cava, Inferior | 3 | 2012 | 459 | 0.170 |
Why?
|
Glottis | 1 | 2021 | 214 | 0.170 |
Why?
|
Lymphoma, T-Cell, Peripheral | 1 | 2021 | 124 | 0.170 |
Why?
|
Lymphoma, Large-Cell, Anaplastic | 1 | 2021 | 167 | 0.170 |
Why?
|
Sarcoma | 2 | 2021 | 1784 | 0.160 |
Why?
|
Gene Rearrangement | 2 | 2021 | 1125 | 0.160 |
Why?
|
Humans | 30 | 2024 | 757566 | 0.160 |
Why?
|
Risk Factors | 6 | 2022 | 73708 | 0.160 |
Why?
|
Viscosity | 1 | 2019 | 335 | 0.160 |
Why?
|
Gene Fusion | 1 | 2021 | 354 | 0.160 |
Why?
|
Hospitals, Pediatric | 2 | 2019 | 1854 | 0.160 |
Why?
|
Polyglycolic Acid | 3 | 2015 | 405 | 0.150 |
Why?
|
Janus Kinase 2 | 1 | 2021 | 537 | 0.150 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2020 | 697 | 0.140 |
Why?
|
Gastroenterology | 1 | 2023 | 571 | 0.140 |
Why?
|
Prescriptions | 1 | 2019 | 386 | 0.140 |
Why?
|
Child | 8 | 2023 | 79782 | 0.130 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2020 | 555 | 0.130 |
Why?
|
Tissue Scaffolds | 6 | 2012 | 925 | 0.130 |
Why?
|
Breast Feeding | 1 | 2023 | 1355 | 0.120 |
Why?
|
Female | 17 | 2024 | 389943 | 0.120 |
Why?
|
Medicine | 1 | 2023 | 940 | 0.120 |
Why?
|
Blood Vessels | 2 | 2011 | 1112 | 0.120 |
Why?
|
Carcinoma, Transitional Cell | 1 | 2021 | 772 | 0.120 |
Why?
|
Guided Tissue Regeneration | 2 | 2011 | 87 | 0.110 |
Why?
|
Male | 14 | 2024 | 358180 | 0.110 |
Why?
|
Follow-Up Studies | 3 | 2019 | 39020 | 0.100 |
Why?
|
Uterine Neoplasms | 1 | 2020 | 1414 | 0.090 |
Why?
|
Infant, Newborn | 2 | 2024 | 26176 | 0.090 |
Why?
|
Vascular Grafting | 1 | 2011 | 152 | 0.090 |
Why?
|
Child, Preschool | 4 | 2019 | 42045 | 0.080 |
Why?
|
Carcinoma | 1 | 2021 | 2330 | 0.080 |
Why?
|
Lymphoma, Mantle-Cell | 1 | 2012 | 237 | 0.080 |
Why?
|
Parents | 1 | 2023 | 3548 | 0.080 |
Why?
|
Repressor Proteins | 1 | 2020 | 2976 | 0.080 |
Why?
|
Treatment Outcome | 3 | 2021 | 64242 | 0.080 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2021 | 2195 | 0.080 |
Why?
|
Cell Transplantation | 1 | 2010 | 472 | 0.080 |
Why?
|
Proto-Oncogene Proteins | 1 | 2020 | 4492 | 0.070 |
Why?
|
Lung | 2 | 2023 | 9973 | 0.070 |
Why?
|
Societies, Medical | 1 | 2019 | 3887 | 0.070 |
Why?
|
Cost of Illness | 1 | 2016 | 1925 | 0.070 |
Why?
|
Macrophages | 2 | 2011 | 5732 | 0.070 |
Why?
|
Longitudinal Studies | 1 | 2022 | 14473 | 0.070 |
Why?
|
Mutation | 3 | 2021 | 29929 | 0.070 |
Why?
|
Patient Discharge | 1 | 2019 | 3428 | 0.070 |
Why?
|
Risk Assessment | 2 | 2017 | 23816 | 0.060 |
Why?
|
Length of Stay | 1 | 2018 | 6384 | 0.060 |
Why?
|
Patient Readmission | 1 | 2019 | 3241 | 0.060 |
Why?
|
Genomics | 4 | 2021 | 5788 | 0.060 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2012 | 1111 | 0.060 |
Why?
|
Glioblastoma | 1 | 2019 | 3480 | 0.060 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2012 | 951 | 0.060 |
Why?
|
Colonoscopy | 1 | 2012 | 1385 | 0.060 |
Why?
|
Extracellular Matrix | 1 | 2011 | 1722 | 0.060 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15781 | 0.050 |
Why?
|
Mice, Inbred C57BL | 4 | 2015 | 21990 | 0.050 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2021 | 5648 | 0.050 |
Why?
|
Ovarian Neoplasms | 1 | 2019 | 4872 | 0.050 |
Why?
|
Cross-Sectional Studies | 1 | 2023 | 25924 | 0.050 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2012 | 1427 | 0.050 |
Why?
|
Poly(A)-Binding Protein I | 1 | 2021 | 15 | 0.050 |
Why?
|
Lysine | 1 | 2006 | 993 | 0.050 |
Why?
|
Glutamic Acid | 1 | 2006 | 1167 | 0.050 |
Why?
|
Immunohistochemistry | 3 | 2021 | 11063 | 0.040 |
Why?
|
Exons | 1 | 2006 | 2392 | 0.040 |
Why?
|
Prevalence | 1 | 2017 | 15640 | 0.040 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2012 | 1842 | 0.040 |
Why?
|
Reproducibility of Results | 1 | 2018 | 20037 | 0.040 |
Why?
|
Incidence | 1 | 2018 | 21217 | 0.040 |
Why?
|
Polyesters | 2 | 2012 | 370 | 0.040 |
Why?
|
Sarcoma, Endometrial Stromal | 1 | 2020 | 93 | 0.040 |
Why?
|
Algorithms | 1 | 2019 | 13952 | 0.040 |
Why?
|
DNA Mutational Analysis | 1 | 2006 | 4107 | 0.040 |
Why?
|
Mice | 6 | 2015 | 81066 | 0.040 |
Why?
|
Phthalazines | 1 | 2019 | 382 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2019 | 13597 | 0.030 |
Why?
|
Lactic Acid | 2 | 2012 | 1133 | 0.030 |
Why?
|
Mice, SCID | 2 | 2012 | 2625 | 0.030 |
Why?
|
Microsatellite Instability | 1 | 2020 | 715 | 0.030 |
Why?
|
Leiomyosarcoma | 1 | 2020 | 423 | 0.030 |
Why?
|
Prognosis | 1 | 2016 | 29488 | 0.030 |
Why?
|
Gene Amplification | 1 | 2020 | 1086 | 0.030 |
Why?
|
Polymers | 2 | 2012 | 1612 | 0.030 |
Why?
|
Adolescent | 2 | 2016 | 87819 | 0.030 |
Why?
|
Databases, Genetic | 1 | 2020 | 1736 | 0.030 |
Why?
|
Bone Marrow Transplantation | 2 | 2011 | 2691 | 0.030 |
Why?
|
Animals | 6 | 2015 | 167718 | 0.030 |
Why?
|
Neoplasms | 1 | 2021 | 21986 | 0.030 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2021 | 9245 | 0.020 |
Why?
|
Intestinal Polyps | 1 | 2012 | 104 | 0.020 |
Why?
|
Guideline Adherence | 1 | 2021 | 2212 | 0.020 |
Why?
|
Cell Survival | 2 | 2011 | 5781 | 0.020 |
Why?
|
Transplantation, Isogeneic | 1 | 2011 | 248 | 0.020 |
Why?
|
United States | 1 | 2019 | 71902 | 0.020 |
Why?
|
Y Chromosome | 1 | 2012 | 205 | 0.020 |
Why?
|
Paracrine Communication | 1 | 2012 | 276 | 0.020 |
Why?
|
Elastin | 1 | 2011 | 300 | 0.020 |
Why?
|
Dendritic Cells | 1 | 2021 | 2720 | 0.020 |
Why?
|
Magnetite Nanoparticles | 1 | 2011 | 315 | 0.020 |
Why?
|
Matrix Metalloproteinases | 1 | 2011 | 392 | 0.020 |
Why?
|
Piperazines | 1 | 2019 | 2511 | 0.020 |
Why?
|
Mice, Transgenic | 2 | 2011 | 9514 | 0.020 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2021 | 2006 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2020 | 3614 | 0.020 |
Why?
|
Cell Line | 2 | 2012 | 15587 | 0.020 |
Why?
|
Bioprosthesis | 1 | 2011 | 591 | 0.020 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2010 | 686 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2012 | 2506 | 0.020 |
Why?
|
Prosthesis Design | 1 | 2012 | 2105 | 0.020 |
Why?
|
Neovascularization, Physiologic | 1 | 2011 | 1332 | 0.010 |
Why?
|
Leukocytes, Mononuclear | 1 | 2011 | 1825 | 0.010 |
Why?
|
Bone Marrow Cells | 1 | 2011 | 2411 | 0.010 |
Why?
|
Phenotype | 1 | 2021 | 16533 | 0.010 |
Why?
|
Collagen | 1 | 2011 | 2634 | 0.010 |
Why?
|
Cell Culture Techniques | 1 | 2010 | 1664 | 0.010 |
Why?
|
Middle Aged | 3 | 2021 | 219192 | 0.010 |
Why?
|
Adult | 3 | 2021 | 219725 | 0.010 |
Why?
|
Aged | 3 | 2021 | 167890 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2021 | 17767 | 0.010 |
Why?
|
Ultrasonography | 1 | 2012 | 5951 | 0.010 |
Why?
|
Endothelial Cells | 1 | 2010 | 3526 | 0.010 |
Why?
|
Cohort Studies | 1 | 2020 | 41190 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2021 | 58558 | 0.010 |
Why?
|
Apoptosis | 1 | 2012 | 9466 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2012 | 11469 | 0.010 |
Why?
|
Models, Biological | 1 | 2010 | 9459 | 0.010 |
Why?
|
Time Factors | 1 | 2012 | 39811 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2011 | 36270 | 0.000 |
Why?
|